IGF-1R modulation of acute GH-induced STAT5 signaling: Role of protein tyrosine phosphatase activity

Molecular Endocrinology

Volumn 27, Issue 11, 2013, Pages 1969-1979

  Gan, Yujun ^a   Zhang, Yue ^a   Buckels, Ashiya ^a   Paterson, Andrew J ^a   Jiang, Jing ^a   Clemens, Thomas L ^c   Zhang, Zhong Yin ^d   Du, Keyong ^e   Chang, Yingzi ^f   Frank, Stuart J ^a,b,g  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e TUFTS MEDICAL CENTER   (United States)

^f A T STILL UNIVERSITY   (United States)

^g BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; GROWTH HORMONE; JANUS KINASE 2; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 1B; PROTEIN TYROSINE PHOSPHATASE SHP 1; PROTEIN TYROSINE PHOSPHATASE SHP 2; SHORT HAIRPIN RNA; SOMATOMEDIN C RECEPTOR; STAT5 PROTEIN; VANADATE SODIUM;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL STRAIN LNCAP; CONTROLLED STUDY; ENZYME ACTIVITY; GENE DELETION; GENE SILENCING; HUMAN; HUMAN CELL; LOXP SITE; NONHUMAN; OSTEOBLAST; PHOTOMORPHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ANIMALS; BENZOFURANS; CELLS, CULTURED; GROWTH HORMONE; HUMANS; JANUS KINASE 2; MICE; MICE, TRANSGENIC; NUCLEAR PROTEINS; OSTEOBLASTS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; QUINOLINES; RECEPTOR, IGF TYPE 1; STAT5 TRANSCRIPTION FACTOR; UBIQUITIN-PROTEIN LIGASES;

EID: 84886414641     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2013-1178     Document Type: Article

References (54)

1. Moller N, Jorgensen JO. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev. 2009;30:152-177.
2. Brooks AJ, Waters MJ. The growth hormone receptor: mechanism of activation and clinical implications. Nat Rev Endocrinol. 2010; 6:515-525.
3. Herrington J, Carter-Su C. Signaling pathways activated by the growth hormone receptor. Trends Endocrinol Metab. 2001;12: 252-257.
4. Frank SJ, Messina JL. 2002 Growth hormone receptor. In: Oppenheim JJ, Feldman M, eds. Cytokine Reference On-Line. London: Academic Press, Harcourt; 1-21.
5. Davey HW, Xie T, McLachlan MJ, Wilkins RJ, Waxman DJ, Grattan DR. STAT5b is required for GH-induced liver IGF-I gene expression. Endocrinology. 2001;142:3836-3841.
6. Woelfle J, Billiard J, Rotwein P. Acute control of insulin-like growth factor-I gene transcription by growth hormone through Stat5b. J Biol Chem. 2003;278:22696-22702.
7. Ullrich A, Gray A, Tam AW, et al. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J. 1986;5:2503-2512.
8. LeRoith D. Insulin-like growth factor I receptor signaling- overlapping or redundant pathways? Endocrinology. 2000;141:1287-1288.
9. Nakae J, Kido Y, Accili D. Distinct and overlapping functions of insulin and IGF-I receptors. Endocr Rev. 2001;22:818-835.
10. Salmon WD, Daughaday WH. A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med. 1957;49:825-836.
11. Daughaday WH. Growth hormone axis overview-somatomedin hypothesis. Pediatr Nephrol. 2000;14:537-540.
12. Le Roith D, Bondy C, Yakar S, Liu JL, Butler A. The somatomedin hypothesis: 2001. Endocr Rev. 2001;22:53-74.
13. Fan Y, Menon RK, Cohen P, et al. Liver-specific deletion of the growth hormone receptor reveals essential role of growth hormone signaling in hepatic lipid metabolism. J Biol Chem. 2009;284: 19937-19944.
14. Lupu F, Terwilliger JD, Lee K, Segre GV, Efstratiadis A. Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol. 2001;229:141-162.
15. Frank SJ. Growth hormone, insulin-like growth factor I, and growth: local knowledge. Endocrinology. 2007;148:1486-1488.
16. Ashcom G, Gurland G, Schwartz J. Growth hormone synergizes with serum growth factors in inducing c-fos transcription in 3T3-F442A cells. Endocrinology. 1992;131:1915-1921.
17. Edmondson SR, Russo VC, McFarlane AC, Wraight CJ, Werther GA. Interactions between growth hormone, insulin-like growth factor I, and basic fibroblast growth factor in melanocyte growth. J Clin Endocrinol Metab. 1999;84:1638-1644.
18. Huang Y, Kim S-O, Yang N, Jiang J, Frank SJ. Physical and functional interaction of GH and IGF-I signaling elements. Mol Endocrinol. 2004;18:1471-1485.
19. Gan Y, Zhang Y, Digirolamo DJ, et al. Deletion of IGF-1 receptor (IGF-IR) in primary osteoblasts reduces GH-induced STAT5 signaling. Mol Endocrinol. 2010;24:644-656.
20. Pasquali C, Curchod ML, Walchli S, et al. Identification of protein tyrosine phosphatases with specificity for the ligand-activated growth hormone receptor. Mol Endocrinol. 2003;17:2228-2239.
21. Gu F, Dube N, Kim JW, et al. Protein tyrosine phosphatase 1B attenuates growth hormone-mediated JAK2-STAT signaling. Mol Cell Biol. 2003;23:3753-3762.
22. Choi JH, Kim HS, Kim SH, et al. Phospholipase C 1 negatively regulates growth hormone signalling by forming a ternary complex with Jak2 and protein tyrosine phosphatase-1B. Nat Cell Biol. 2006;8:1389-1397.
23. Pilecka I, Patrignani C, Pescini R, et al. Protein-tyrosine phosphatase H1 controls growth hormone receptor signaling and systemic growth. J Biol Chem. 2007;282:35405-35415.
24. Ram PA, Waxman DJ. Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase. J Biol Chem. 1997;272:17694-17702.
25. Hackett RH, Wang YD, Sweitzer S, Feldman G, Wood WI, Larner AC. Mapping of a cytoplasmic domain of the human growth hormone receptor that regulates rates of inactivation of Jak2 and Stat proteins. J Biol Chem. 1997;272:11128-11132.
26. Kim SO, Jiang J, Yi W, Feng GS, Frank SJ. Involvement of the Src homology 2-containing tyrosine phosphatase SHP-2 in growth hormone signaling. J Biol Chem. 1998;273:2344-2354.
27. Stofega MR, Herrington J, Billestrup N, Carter-Su C. Mutation of the SHP-2 binding site in growth hormone (GH) receptor prolongs GH-promoted tyrosyl phosphorylation of GH receptor, JAK2, and STAT5B. Mol Endocrinol. 2000;14:1338-1350.
28. Stofega MR, Wang H, Ullrich A, Carter-Su C. Growth hormone regulation of SIRP and SHP-2 tyrosyl phosphorylation and association. J Biol Chem. 1998;273:7112-7117.
29. De Rocca Serra-Nedelec A, Edouard T, Treguer K, et al. Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature. Proc Natl Acad Sci USA. 2012;109: 4257-4262.
30. Zhang Y, Guan R, Jiang J, et al. Growth hormone (GH)-induced dimerization inhibits phorbol ester-stimulated GH receptor proteolysis. J Biol Chem. 2001;276:24565-24573.
31. Jiang J, Liang L, Kim SO, Zhang Y, Mandler R, Frank SJ. Growth hormone-dependent tyrosine phosphorylation of a GH receptor-associated high molecular weight protein immunologically related to JAK2. Biochem Biophys Res Commun. 1998;253:774-779.
32. DiGirolamo DJ, Mukherjee A, Fulzele K, et al. Mode of growth hormone action in osteoblasts. J Biol Chem. 2007;282:31666-31674.
33. Chang Y, Ceacareanu B, Zhuang D, et al. Counter-regulatory function of protein tyrosine phosphatase 1B in platelet-derived growth factor-or fibroblast growth factor-induced motility and proliferation of cultured smooth muscle cells and in neointima formation. Arterioscler Thromb Vasc Biol. 2006;26:501-507.
34. Sreejayan N, Lin Y, Hassid A. NO attenuates insulin signaling and motility in aortic smooth muscle cells via protein tyrosine phosphatase 1B-mediated mechanism. Arterioscler Thromb Vasc Biol. 2002;22:1086-1092.
35. Flint AJ, Tiganis T, Barford D, Tonks NK. Development of "sub-strate-trapping" mutants to identify physiological substrates of protein tyrosine phosphatases. Proc Natl Acad Sci USA. 1997;94: 1680-1685.
36. Bettaieb A, Bakke J, Nagata N, et al. Protein-tyrosine phosphatase 1B regulates pyruvate kinase M2 tyrosine phosphorylation. J Biol Chem. 2013;288(24):17360-17371.
37. Kato S, Ding J, Pisck E, Jhala US, Du K. COP1 functions as a FoxO1 ubiquitin E3 ligase to regulate FoxO1-mediated gene expression. J Biol Chem. 2008;283:35464-35473.
38. Frank SJ, Wang X, He K, et al. In vivo imaging of hepatic growth hormone signaling. Mol Endocrinol. 2006;20:2819-2830.
39. Xu J, Zhang Y, Berry PA, et al. Growth hormone signaling in human T47D breast cancer cells: potential role for a growth hormone receptor-prolactin receptor complex. Mol Endocrinol. 2011; 25:597-610.
40. Zhang M, Xuan S, Bouxsein ML, et al. Osteoblast-specific knock-out of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem. 2002;277:44005-44012.
41. Tiganis T, Bennett AM. Protein tyrosine phosphatase function: the substrate perspective. Biochem J. 2007;402:1-15.
42. Zhang J, Somani AK, Siminovitch KA. Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signalling. Semin Immunol. 2000;12:361-378.
43. Carver KC, Piazza TM, Schuler LA. Prolactin enhances insulin-like growth factor I receptor phosphorylation by decreasing its association with the tyrosine phosphatase SHP-2 in MCF-7 breast cancer cells. J Biol Chem. 285:8003-8012.
44. Frangioni JV, Beahm PH, Shifrin V, Jost CA, Neel BG. The non-transmembrane tyrosine phosphatase PTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence. Cell. 1992;68:545-560.
45. Tonks NK. PTP1B: from the sidelines to the front lines!. FEBS Lett. 2003;546:140-148.
46. Elchebly M, Payette P, Michaliszyn E, et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science. 1999;283:1544-1548.
47. Sangwan V, Abella J, Lai A, et al. Protein-tyrosine phosphatase 1B modulates early endosome fusion and trafficking of Met and epidermal growth factor receptors. J Biol Chem. 2011;286:45000-45013.
48. Carbone CJ, Zheng H, Bhattacharya S, et al. Protein tyrosine phosphatase 1B is a key regulator of IFNAR1 endocytosis and a target for antiviral therapies. Proc Natl Acad Sci USA. 2012;109:19226-19231.
49. Wiesmann C, Barr KJ, Kung J, et al. Allosteric inhibition of protein tyrosine phosphatase 1B. Nat Struct Mol Biol. 2004;11:730-737.
50. Sun T, Ye F, Ding H, Chen K, Jiang H, Shen X. Protein tyrosine phosphatase 1B regulates TGF 1-induced Smad2 activation through PI3 kinase-dependent pathway. Cytokine. 2006;35: 88-94.
51. Ma F, Wei Z, Shi C, et al. Signaling cross talk between growth hormone (GH) and insulin-like growth factor-I (IGF-I) in pancreatic islet beta-cells. Mol Endocrinol. 2011;25:2119-2133.
52. Yi C, Deng XW. COP1-from plant photomorphogenesis to mammalian tumorigenesis. Trends Cell Biol. 2005;15:618-625.
53. Marine JC. Spotlight on the role of COP1 in tumorigenesis. Nat Rev Cancer. 2012;12:455-464.
54. Ren W, Sun Y, Cheema S, Du K. Interaction of constitutive photo-morphogenesis 1 protein with protein-tyrosine phosphatase 1B suppresses protein-tyrosine phosphatase 1B activity and enhances insulin signaling. J Biol Chem. 2013;288:10902-10913.